Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Rimassa, L.; Cicin, I.; Blanc, J. F.; Klümpen, H. J.; Zagonel, V.; Tran, A.; Kim, S. C. H.; Lin, Z. Z.; Tam, V. C.; Hazra, S.; Mangeshkar, M.; El-Khoueiry, A.; Cheng, A. L.; Meyer, T.; Kelley, R. K.; Abou-Alfa, G. K.
Abstract Title: Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 224s
Language: English
ACCESSION: WOS:000442916001666
DOI: 10.1200/JCO.2018.36.15_suppl.4090
PROVIDER: wos
Notes: Meeting Abstract: 4090 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    583 Abou-Alfa